Tiziana Life Sciences PLC ( NASDAQ:TLSA, LSE:TILS, FRA:RTRA, OTC:TIZAF ) will host a conference call and audio webcast on Wednesday, September 8, at 9.15pm BST (4:15pm ET) to discuss its recently announced exclusive license agreement to evaluate Foralumab, the company's novel, fully human anti-CD3 monoclonal antibody, in conjunction with allogenic CAR T candidates for cancer treatment. Allergy Therapeutics PLC ( AIM:AGY, FRA:HHU ) will host a webinar entitled 'VLP Peanut; a next generation peanut allergy immunotherapy', on Friday 17 September 2021 at 2pm BST (9am ET), with an introduction from chief executive officer Manuel Llobet and a presentation by key opinion leader Dr Mo Shamji, reader in immunology & allergy at Imperial College London. Faron Pharmaceuticals Ltd announced that Dr Juho Jalkanen, chief development officer, will present at the virtual HC Wainwright Global Investor Conference, with the presentation available on-demand from Monday, September 13 at 12pm BST (7am ET), 2pm EEST).